Intra-Cellular Therapies Inc
NASDAQ:ITCI
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Price:
131.87
USD
-0.04%
Market Closed
Market Cap:
$14B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Intra-Cellular Therapies Inc
NASDAQ:ITCI
|
US |
|
C
|
Charoong Thai Wire & Cable PCL
SET:CTW
|
TH |
|
VEEM Ltd
ASX:VEE
|
AU |
|
Southstone Minerals Ltd
XTSX:SML
|
CA |
|
Gabriel Holding A/S
CSE:GABR
|
DK |
|
Century Communities Inc
NYSE:CCS
|
US |
|
Abundance International Ltd
SGX:541
|
SG |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ITCI's stock price target?
Not Available
ITCI doesn't have any price targets made by Wall Street professionals.
What is Intra-Cellular Therapies Inc's Revenue forecast?
Projected CAGR
48%
48%
For the last 12 years the
compound annual growth rate for
Intra-Cellular Therapies Inc's revenue is
57%.
The projected
CAGR
for the next 3 years is
48%.
